Up a level |
Number of items: 1.
Fizazi, Karim ORCID: 0000-0002-6068-9474, Azad, Arun A ORCID: 0000-0001-7350-5622, Matsubara, Nobuaki, Carles, Joan, Fay, Andre P, De Giorgi, Ugo, Joung, Jae Young, Fong, Peter CC, Voog, Eric, Jones, Robert J ORCID: 0000-0001-5608-001X et al (show 11 more authors)
(2024)
First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial.
Nature medicine, 30 (1).
pp. 257-264.